nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—TYMS—Capecitabine—kidney cancer	0.237	0.306	CbGbCtD
Leucovorin—TYMS—Gemcitabine—kidney cancer	0.164	0.212	CbGbCtD
Leucovorin—ABCC3—Vincristine—kidney cancer	0.0663	0.0857	CbGbCtD
Leucovorin—ABCC4—Sorafenib—kidney cancer	0.0522	0.0674	CbGbCtD
Leucovorin—ABCC4—Sunitinib—kidney cancer	0.0423	0.0546	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—kidney cancer	0.0414	0.0536	CbGbCtD
Leucovorin—ABCC2—Paclitaxel—kidney cancer	0.0349	0.0452	CbGbCtD
Leucovorin—ABCC2—Sorafenib—kidney cancer	0.031	0.0401	CbGbCtD
Leucovorin—ABCC2—Vinblastine—kidney cancer	0.0306	0.0396	CbGbCtD
Leucovorin—ABCC2—Vincristine—kidney cancer	0.0301	0.0389	CbGbCtD
Leucovorin—ABCC2—Sunitinib—kidney cancer	0.0251	0.0325	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—kidney cancer	0.0188	0.0243	CbGbCtD
Leucovorin—TYMS—Docetaxel—Paclitaxel—kidney cancer	0.00128	0.27	CbGdCrCtD
Leucovorin—TYMS—nephron tubule—kidney cancer	0.00108	0.111	CbGeAlD
Leucovorin—TYMS—E2F transcription factor network—TFE3—kidney cancer	0.000976	0.0252	CbGpPWpGaD
Leucovorin—ABCC2—Irinotecan Pathway—BCHE—kidney cancer	0.000931	0.024	CbGpPWpGaD
Leucovorin—TYMS—cortex of kidney—kidney cancer	0.000928	0.0952	CbGeAlD
Leucovorin—TYMS—Nucleotide metabolism—PPAT—kidney cancer	0.000887	0.0229	CbGpPWpGaD
Leucovorin—TYMS—gonad—kidney cancer	0.000884	0.0906	CbGeAlD
Leucovorin—TYMS—Nucleotide metabolism—APRT—kidney cancer	0.000825	0.0213	CbGpPWpGaD
Leucovorin—ABCC3—renal system—kidney cancer	0.000808	0.0829	CbGeAlD
Leucovorin—ABCC3—kidney—kidney cancer	0.000781	0.0801	CbGeAlD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000757	0.0195	CbGpPWpGaD
Leucovorin—ABCC4—nephron tubule—kidney cancer	0.000734	0.0753	CbGeAlD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000712	0.0184	CbGpPWpGaD
Leucovorin—ABCC2—nephron tubule—kidney cancer	0.00071	0.0729	CbGeAlD
Leucovorin—ABCC4—renal system—kidney cancer	0.000667	0.0684	CbGeAlD
Leucovorin—ABCC2—renal system—kidney cancer	0.000646	0.0662	CbGeAlD
Leucovorin—ABCC4—kidney—kidney cancer	0.000645	0.0662	CbGeAlD
Leucovorin—ABCC4—cortex of kidney—kidney cancer	0.000628	0.0644	CbGeAlD
Leucovorin—ABCC2—kidney—kidney cancer	0.000624	0.064	CbGeAlD
Leucovorin—TYMS—Sirolimus—Everolimus—kidney cancer	0.000615	0.13	CbGdCrCtD
Leucovorin—TYMS—Sirolimus—Temsirolimus—kidney cancer	0.000615	0.13	CbGdCrCtD
Leucovorin—TYMS—Gefitinib—Erlotinib—kidney cancer	0.000613	0.129	CbGdCrCtD
Leucovorin—ABCC2—cortex of kidney—kidney cancer	0.000608	0.0624	CbGeAlD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.0006	0.0155	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CDH6—kidney cancer	0.000537	0.0138	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—APAF1—kidney cancer	0.000527	0.0136	CbGpPWpGaD
Leucovorin—ABCC2—Irinotecan Pathway—APC—kidney cancer	0.000505	0.013	CbGpPWpGaD
Leucovorin—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000456	0.0118	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000435	0.0112	CbGpPWpGaD
Leucovorin—ABCC3—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.000415	0.0107	CbGpPWpGaD
Leucovorin—TYMS—Vinorelbine—Vincristine—kidney cancer	0.000411	0.0866	CbGdCrCtD
Leucovorin—TYMS—Vinorelbine—Vinblastine—kidney cancer	0.000411	0.0866	CbGdCrCtD
Leucovorin—ABCC4—Ectoderm Differentiation—NF2—kidney cancer	0.000407	0.0105	CbGpPWpGaD
Leucovorin—ABCC4—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.000391	0.0101	CbGpPWpGaD
Leucovorin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000362	0.00933	CbGpPWpGaD
Leucovorin—TYMS—Vincristine—Vinblastine—kidney cancer	0.000351	0.074	CbGdCrCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000345	0.00889	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—SLC5A3—kidney cancer	0.000337	0.00869	CbGpPWpGaD
Leucovorin—ABCC2—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.000329	0.0085	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—SLC5A3—kidney cancer	0.000317	0.00817	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—KEAP1—kidney cancer	0.000295	0.0076	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—PSMD7—kidney cancer	0.00029	0.00747	CbGpPWpGaD
Leucovorin—TYMS—Vinblastine—Vincristine—kidney cancer	0.000282	0.0595	CbGdCrCtD
Leucovorin—ABCC4—NRF2 pathway—KEAP1—kidney cancer	0.000277	0.00714	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—SYNE2—kidney cancer	0.000271	0.00698	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—HNF1B—kidney cancer	0.000268	0.00691	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC5A3—kidney cancer	0.000267	0.00689	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—KCNMA1—kidney cancer	0.000261	0.00674	CbGpPWpGaD
Leucovorin—Anorexia—Sunitinib—kidney cancer	0.000261	0.00151	CcSEcCtD
Leucovorin—Abdominal pain—Vinblastine—kidney cancer	0.00026	0.0015	CcSEcCtD
Leucovorin—Body temperature increased—Everolimus—kidney cancer	0.000259	0.00149	CcSEcCtD
Leucovorin—Abdominal pain—Everolimus—kidney cancer	0.000259	0.00149	CcSEcCtD
Leucovorin—Gastrointestinal pain—Erlotinib—kidney cancer	0.000259	0.00149	CcSEcCtD
Leucovorin—Infection—Dactinomycin—kidney cancer	0.000257	0.00149	CcSEcCtD
Leucovorin—Neuropathy—Doxorubicin—kidney cancer	0.000256	0.00148	CcSEcCtD
Leucovorin—Leukopenia—Vincristine—kidney cancer	0.000254	0.00147	CcSEcCtD
Leucovorin—Thrombocytopenia—Dactinomycin—kidney cancer	0.000254	0.00146	CcSEcCtD
Leucovorin—Dyspnoea—Sorafenib—kidney cancer	0.000254	0.00146	CcSEcCtD
Leucovorin—Dyspepsia—Sorafenib—kidney cancer	0.00025	0.00145	CcSEcCtD
Leucovorin—Abdominal pain—Erlotinib—kidney cancer	0.00025	0.00144	CcSEcCtD
Leucovorin—Body temperature increased—Erlotinib—kidney cancer	0.00025	0.00144	CcSEcCtD
Leucovorin—Ill-defined disorder—Gemcitabine—kidney cancer	0.00025	0.00144	CcSEcCtD
Leucovorin—Decreased appetite—Sorafenib—kidney cancer	0.000247	0.00143	CcSEcCtD
Leucovorin—Anorexia—Dactinomycin—kidney cancer	0.000247	0.00143	CcSEcCtD
Leucovorin—Nausea—Pazopanib—kidney cancer	0.000247	0.00142	CcSEcCtD
Leucovorin—Convulsion—Vincristine—kidney cancer	0.000246	0.00142	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000246	0.00142	CcSEcCtD
Leucovorin—Fatigue—Sorafenib—kidney cancer	0.000245	0.00142	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—PSMD7—kidney cancer	0.000244	0.0063	CbGpPWpGaD
Leucovorin—Dyspnoea—Sunitinib—kidney cancer	0.000244	0.00141	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000244	0.0063	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000244	0.0063	CbGpPWpGaD
Leucovorin—Constipation—Sorafenib—kidney cancer	0.000243	0.0014	CcSEcCtD
Leucovorin—Malaise—Gemcitabine—kidney cancer	0.000243	0.0014	CcSEcCtD
Leucovorin—Hypersensitivity—Vinblastine—kidney cancer	0.000242	0.0014	CcSEcCtD
Leucovorin—Hypersensitivity—Everolimus—kidney cancer	0.000241	0.00139	CcSEcCtD
Leucovorin—Dyspepsia—Sunitinib—kidney cancer	0.000241	0.00139	CcSEcCtD
Leucovorin—Leukopenia—Gemcitabine—kidney cancer	0.000241	0.00139	CcSEcCtD
Leucovorin—Decreased appetite—Sunitinib—kidney cancer	0.000238	0.00137	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000236	0.00136	CcSEcCtD
Leucovorin—Asthenia—Vinblastine—kidney cancer	0.000236	0.00136	CcSEcCtD
Leucovorin—Fatigue—Sunitinib—kidney cancer	0.000236	0.00136	CcSEcCtD
Leucovorin—Asthenia—Everolimus—kidney cancer	0.000235	0.00136	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—JUND—kidney cancer	0.000234	0.00604	CbGpPWpGaD
Leucovorin—Constipation—Sunitinib—kidney cancer	0.000234	0.00135	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—KEAP1—kidney cancer	0.000234	0.00602	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000233	0.00134	CcSEcCtD
Leucovorin—Chills—Paclitaxel—kidney cancer	0.000232	0.00134	CcSEcCtD
Leucovorin—Neuropathy peripheral—Capecitabine—kidney cancer	0.000232	0.00134	CcSEcCtD
Leucovorin—Pruritus—Everolimus—kidney cancer	0.000232	0.00134	CcSEcCtD
Leucovorin—Anaphylactic shock—Vincristine—kidney cancer	0.000232	0.00134	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000231	0.00597	CbGpPWpGaD
Leucovorin—Stomatitis—Capecitabine—kidney cancer	0.000231	0.00133	CcSEcCtD
Leucovorin—Infection—Vincristine—kidney cancer	0.00023	0.00133	CcSEcCtD
Leucovorin—Alopecia—Paclitaxel—kidney cancer	0.000229	0.00132	CcSEcCtD
Leucovorin—Asthenia—Erlotinib—kidney cancer	0.000227	0.00131	CcSEcCtD
Leucovorin—Thrombocytopenia—Vincristine—kidney cancer	0.000227	0.00131	CcSEcCtD
Leucovorin—Discomfort—Gemcitabine—kidney cancer	0.000226	0.00131	CcSEcCtD
Leucovorin—Urticaria—Sorafenib—kidney cancer	0.000226	0.0013	CcSEcCtD
Leucovorin—Erythema—Paclitaxel—kidney cancer	0.000225	0.0013	CcSEcCtD
Leucovorin—Decreased appetite—Dactinomycin—kidney cancer	0.000225	0.0013	CcSEcCtD
Leucovorin—Diarrhoea—Vinblastine—kidney cancer	0.000225	0.0013	CcSEcCtD
Leucovorin—Abdominal pain—Sorafenib—kidney cancer	0.000225	0.0013	CcSEcCtD
Leucovorin—Body temperature increased—Sorafenib—kidney cancer	0.000225	0.0013	CcSEcCtD
Leucovorin—Diarrhoea—Everolimus—kidney cancer	0.000224	0.00129	CcSEcCtD
Leucovorin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000224	0.00129	CcSEcCtD
Leucovorin—Pruritus—Erlotinib—kidney cancer	0.000224	0.00129	CcSEcCtD
Leucovorin—Fatigue—Dactinomycin—kidney cancer	0.000223	0.00129	CcSEcCtD
Leucovorin—Anorexia—Vincristine—kidney cancer	0.000221	0.00127	CcSEcCtD
Leucovorin—Dysgeusia—Paclitaxel—kidney cancer	0.000221	0.00127	CcSEcCtD
Leucovorin—Anaphylactic shock—Gemcitabine—kidney cancer	0.00022	0.00127	CcSEcCtD
Leucovorin—Infection—Gemcitabine—kidney cancer	0.000218	0.00126	CcSEcCtD
Leucovorin—Dizziness—Vinblastine—kidney cancer	0.000218	0.00126	CcSEcCtD
Leucovorin—Dizziness—Everolimus—kidney cancer	0.000217	0.00125	CcSEcCtD
Leucovorin—Abdominal pain—Sunitinib—kidney cancer	0.000216	0.00125	CcSEcCtD
Leucovorin—Body temperature increased—Sunitinib—kidney cancer	0.000216	0.00125	CcSEcCtD
Leucovorin—Diarrhoea—Erlotinib—kidney cancer	0.000216	0.00125	CcSEcCtD
Leucovorin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000215	0.00124	CcSEcCtD
Leucovorin—Renal failure acute—Doxorubicin—kidney cancer	0.000214	0.00124	CcSEcCtD
Leucovorin—Feeling abnormal—Dactinomycin—kidney cancer	0.000214	0.00123	CcSEcCtD
Leucovorin—Skin disorder—Gemcitabine—kidney cancer	0.000213	0.00123	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—IGF2—kidney cancer	0.000212	0.00547	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000212	0.00122	CcSEcCtD
Leucovorin—Hypersensitivity—Sorafenib—kidney cancer	0.00021	0.00121	CcSEcCtD
Leucovorin—Anorexia—Gemcitabine—kidney cancer	0.000209	0.00121	CcSEcCtD
Leucovorin—Vomiting—Vinblastine—kidney cancer	0.000209	0.00121	CcSEcCtD
Leucovorin—Dizziness—Erlotinib—kidney cancer	0.000209	0.00121	CcSEcCtD
Leucovorin—Ill-defined disorder—Paclitaxel—kidney cancer	0.000209	0.00121	CcSEcCtD
Leucovorin—Vomiting—Everolimus—kidney cancer	0.000208	0.0012	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—kidney cancer	0.000208	0.0012	CcSEcCtD
Leucovorin—Rash—Everolimus—kidney cancer	0.000207	0.00119	CcSEcCtD
Leucovorin—Dermatitis—Everolimus—kidney cancer	0.000206	0.00119	CcSEcCtD
Leucovorin—Abdominal pain—Dactinomycin—kidney cancer	0.000205	0.00118	CcSEcCtD
Leucovorin—Body temperature increased—Dactinomycin—kidney cancer	0.000205	0.00118	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000205	0.00118	CcSEcCtD
Leucovorin—Asthenia—Sorafenib—kidney cancer	0.000204	0.00118	CcSEcCtD
Leucovorin—Malaise—Paclitaxel—kidney cancer	0.000203	0.00117	CcSEcCtD
Leucovorin—Syncope—Paclitaxel—kidney cancer	0.000202	0.00117	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—kidney cancer	0.000202	0.00117	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF2—kidney cancer	0.000202	0.00521	CbGpPWpGaD
Leucovorin—Leukopenia—Paclitaxel—kidney cancer	0.000202	0.00116	CcSEcCtD
Leucovorin—Hypersensitivity—Sunitinib—kidney cancer	0.000202	0.00116	CcSEcCtD
Leucovorin—Decreased appetite—Vincristine—kidney cancer	0.000201	0.00116	CcSEcCtD
Leucovorin—Pruritus—Sorafenib—kidney cancer	0.000201	0.00116	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000201	0.00519	CbGpPWpGaD
Leucovorin—Vomiting—Erlotinib—kidney cancer	0.000201	0.00116	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Vincristine—kidney cancer	0.0002	0.00115	CcSEcCtD
Leucovorin—Fatigue—Vincristine—kidney cancer	0.0002	0.00115	CcSEcCtD
Leucovorin—Rash—Erlotinib—kidney cancer	0.000199	0.00115	CcSEcCtD
Leucovorin—Dermatitis—Erlotinib—kidney cancer	0.000199	0.00115	CcSEcCtD
Leucovorin—Loss of consciousness—Paclitaxel—kidney cancer	0.000198	0.00114	CcSEcCtD
Leucovorin—Constipation—Vincristine—kidney cancer	0.000198	0.00114	CcSEcCtD
Leucovorin—Asthenia—Sunitinib—kidney cancer	0.000196	0.00113	CcSEcCtD
Leucovorin—Dyspnoea—Gemcitabine—kidney cancer	0.000196	0.00113	CcSEcCtD
Leucovorin—Nausea—Vinblastine—kidney cancer	0.000195	0.00113	CcSEcCtD
Leucovorin—Convulsion—Paclitaxel—kidney cancer	0.000195	0.00113	CcSEcCtD
Leucovorin—Nausea—Everolimus—kidney cancer	0.000195	0.00112	CcSEcCtD
Leucovorin—Diarrhoea—Sorafenib—kidney cancer	0.000195	0.00112	CcSEcCtD
Leucovorin—Pruritus—Sunitinib—kidney cancer	0.000194	0.00112	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—PAX6—kidney cancer	0.000193	0.00499	CbGpPWpGaD
Leucovorin—Decreased appetite—Gemcitabine—kidney cancer	0.000191	0.0011	CcSEcCtD
Leucovorin—Hypersensitivity—Dactinomycin—kidney cancer	0.000191	0.0011	CcSEcCtD
Leucovorin—Chills—Capecitabine—kidney cancer	0.000191	0.0011	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00019	0.00109	CcSEcCtD
Leucovorin—Discomfort—Paclitaxel—kidney cancer	0.00019	0.00109	CcSEcCtD
Leucovorin—Fatigue—Gemcitabine—kidney cancer	0.000189	0.00109	CcSEcCtD
Leucovorin—Gastrointestinal pain—Vincristine—kidney cancer	0.000189	0.00109	CcSEcCtD
Leucovorin—Dizziness—Sorafenib—kidney cancer	0.000188	0.00109	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000188	0.00485	CbGpPWpGaD
Leucovorin—Constipation—Gemcitabine—kidney cancer	0.000188	0.00108	CcSEcCtD
Leucovorin—Nausea—Erlotinib—kidney cancer	0.000188	0.00108	CcSEcCtD
Leucovorin—Alopecia—Capecitabine—kidney cancer	0.000188	0.00108	CcSEcCtD
Leucovorin—Diarrhoea—Sunitinib—kidney cancer	0.000187	0.00108	CcSEcCtD
Leucovorin—Asthenia—Dactinomycin—kidney cancer	0.000186	0.00107	CcSEcCtD
Leucovorin—Confusional state—Paclitaxel—kidney cancer	0.000185	0.00107	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000185	0.00107	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000185	0.00477	CbGpPWpGaD
Leucovorin—Erythema—Capecitabine—kidney cancer	0.000185	0.00107	CcSEcCtD
Leucovorin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000184	0.00106	CcSEcCtD
Leucovorin—Body temperature increased—Vincristine—kidney cancer	0.000183	0.00106	CcSEcCtD
Leucovorin—Abdominal pain—Vincristine—kidney cancer	0.000183	0.00106	CcSEcCtD
Leucovorin—Infection—Paclitaxel—kidney cancer	0.000183	0.00105	CcSEcCtD
Leucovorin—Dysgeusia—Capecitabine—kidney cancer	0.000181	0.00104	CcSEcCtD
Leucovorin—Dizziness—Sunitinib—kidney cancer	0.000181	0.00104	CcSEcCtD
Leucovorin—Feeling abnormal—Gemcitabine—kidney cancer	0.000181	0.00104	CcSEcCtD
Leucovorin—Shock—Paclitaxel—kidney cancer	0.000181	0.00104	CcSEcCtD
Leucovorin—Vomiting—Sorafenib—kidney cancer	0.000181	0.00104	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000181	0.00104	CcSEcCtD
Leucovorin—Thrombocytopenia—Paclitaxel—kidney cancer	0.00018	0.00104	CcSEcCtD
Leucovorin—Rash—Sorafenib—kidney cancer	0.000179	0.00104	CcSEcCtD
Leucovorin—Dermatitis—Sorafenib—kidney cancer	0.000179	0.00103	CcSEcCtD
Leucovorin—Skin disorder—Paclitaxel—kidney cancer	0.000179	0.00103	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	0.000178	0.0046	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—SLC5A5—kidney cancer	0.000178	0.00458	CbGpPWpGaD
Leucovorin—Diarrhoea—Dactinomycin—kidney cancer	0.000177	0.00102	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000177	0.00456	CbGpPWpGaD
Leucovorin—Anorexia—Paclitaxel—kidney cancer	0.000175	0.00101	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—kidney cancer	0.000175	0.00452	CbGpPWpGaD
Leucovorin—Vomiting—Sunitinib—kidney cancer	0.000174	0.001	CcSEcCtD
Leucovorin—Body temperature increased—Gemcitabine—kidney cancer	0.000174	0.001	CcSEcCtD
Leucovorin—Rash—Sunitinib—kidney cancer	0.000173	0.000996	CcSEcCtD
Leucovorin—Dermatitis—Sunitinib—kidney cancer	0.000172	0.000995	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—SLC2A1—kidney cancer	0.000172	0.00443	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Capecitabine—kidney cancer	0.000172	0.00099	CcSEcCtD
Leucovorin—Hypersensitivity—Vincristine—kidney cancer	0.000171	0.000984	CcSEcCtD
Leucovorin—Nausea—Sorafenib—kidney cancer	0.000169	0.000975	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—SLC5A5—kidney cancer	0.000167	0.00431	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—CDKN2A—kidney cancer	0.000167	0.0043	CbGpPWpGaD
Leucovorin—Malaise—Capecitabine—kidney cancer	0.000167	0.000962	CcSEcCtD
Leucovorin—Asthenia—Vincristine—kidney cancer	0.000166	0.000959	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000166	0.00428	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000166	0.00428	CbGpPWpGaD
Leucovorin—Syncope—Capecitabine—kidney cancer	0.000166	0.000957	CcSEcCtD
Leucovorin—Leukopenia—Capecitabine—kidney cancer	0.000166	0.000955	CcSEcCtD
Leucovorin—TYMS—Azacitidine—Gemcitabine—kidney cancer	0.000165	0.0349	CbGdCrCtD
Leucovorin—Vomiting—Dactinomycin—kidney cancer	0.000165	0.000951	CcSEcCtD
Leucovorin—Dyspnoea—Paclitaxel—kidney cancer	0.000164	0.000946	CcSEcCtD
Leucovorin—Rash—Dactinomycin—kidney cancer	0.000163	0.000943	CcSEcCtD
Leucovorin—Nausea—Sunitinib—kidney cancer	0.000163	0.000938	CcSEcCtD
Leucovorin—Loss of consciousness—Capecitabine—kidney cancer	0.000163	0.000938	CcSEcCtD
Leucovorin—Dyspepsia—Paclitaxel—kidney cancer	0.000162	0.000934	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—SLC2A1—kidney cancer	0.000161	0.00416	CbGpPWpGaD
Leucovorin—Decreased appetite—Paclitaxel—kidney cancer	0.00016	0.000922	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—EGR1—kidney cancer	0.000159	0.00411	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000159	0.000916	CcSEcCtD
Leucovorin—Fatigue—Paclitaxel—kidney cancer	0.000159	0.000915	CcSEcCtD
Leucovorin—Diarrhoea—Vincristine—kidney cancer	0.000158	0.000914	CcSEcCtD
Leucovorin—Asthenia—Gemcitabine—kidney cancer	0.000158	0.000909	CcSEcCtD
Leucovorin—Constipation—Paclitaxel—kidney cancer	0.000157	0.000907	CcSEcCtD
Leucovorin—Discomfort—Capecitabine—kidney cancer	0.000156	0.000898	CcSEcCtD
Leucovorin—Pruritus—Gemcitabine—kidney cancer	0.000155	0.000897	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000155	0.00401	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—L1CAM—kidney cancer	0.000155	0.00399	CbGpPWpGaD
Leucovorin—Nausea—Dactinomycin—kidney cancer	0.000154	0.000888	CcSEcCtD
Leucovorin—Dizziness—Vincristine—kidney cancer	0.000153	0.000884	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.000153	0.00394	CbGpPWpGaD
Leucovorin—Confusional state—Capecitabine—kidney cancer	0.000152	0.000878	CcSEcCtD
Leucovorin—Feeling abnormal—Paclitaxel—kidney cancer	0.000152	0.000874	CcSEcCtD
Leucovorin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00015	0.000868	CcSEcCtD
Leucovorin—Diarrhoea—Gemcitabine—kidney cancer	0.00015	0.000867	CcSEcCtD
Leucovorin—Infection—Capecitabine—kidney cancer	0.00015	0.000865	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—EGR1—kidney cancer	0.00015	0.00387	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00015	0.00386	CbGpPWpGaD
Leucovorin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.00015	0.000863	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—EGR1—kidney cancer	0.000149	0.00385	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000149	0.00384	CbGpPWpGaD
Leucovorin—Stomatitis—Doxorubicin—kidney cancer	0.000149	0.000858	CcSEcCtD
Leucovorin—Shock—Capecitabine—kidney cancer	0.000148	0.000857	CcSEcCtD
Leucovorin—Thrombocytopenia—Capecitabine—kidney cancer	0.000148	0.000853	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CDKN1B—kidney cancer	0.000148	0.00381	CbGpPWpGaD
Leucovorin—Vomiting—Vincristine—kidney cancer	0.000147	0.000849	CcSEcCtD
Leucovorin—Skin disorder—Capecitabine—kidney cancer	0.000147	0.000846	CcSEcCtD
Leucovorin—Urticaria—Paclitaxel—kidney cancer	0.000146	0.000843	CcSEcCtD
Leucovorin—Rash—Vincristine—kidney cancer	0.000146	0.000842	CcSEcCtD
Leucovorin—Dermatitis—Vincristine—kidney cancer	0.000146	0.000842	CcSEcCtD
Leucovorin—Abdominal pain—Paclitaxel—kidney cancer	0.000145	0.000839	CcSEcCtD
Leucovorin—Body temperature increased—Paclitaxel—kidney cancer	0.000145	0.000839	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—kidney cancer	0.000145	0.00374	CbGpPWpGaD
Leucovorin—Anorexia—Capecitabine—kidney cancer	0.000144	0.00083	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—GSTP1—kidney cancer	0.000143	0.00369	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC5A5—kidney cancer	0.000141	0.00364	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.00014	0.00362	CbGpPWpGaD
Leucovorin—Vomiting—Gemcitabine—kidney cancer	0.00014	0.000806	CcSEcCtD
Leucovorin—Rash—Gemcitabine—kidney cancer	0.000139	0.000799	CcSEcCtD
Leucovorin—Dermatitis—Gemcitabine—kidney cancer	0.000138	0.000798	CcSEcCtD
Leucovorin—Nausea—Vincristine—kidney cancer	0.000138	0.000794	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—kidney cancer	0.000136	0.00352	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000136	0.00352	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC2A1—kidney cancer	0.000136	0.00351	CbGpPWpGaD
Leucovorin—Hypersensitivity—Paclitaxel—kidney cancer	0.000136	0.000782	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000135	0.00349	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—GSTP1—kidney cancer	0.000135	0.00347	CbGpPWpGaD
Leucovorin—Dyspnoea—Capecitabine—kidney cancer	0.000135	0.000776	CcSEcCtD
Leucovorin—Dyspepsia—Capecitabine—kidney cancer	0.000133	0.000767	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000132	0.00341	CbGpPWpGaD
Leucovorin—Asthenia—Paclitaxel—kidney cancer	0.000132	0.000761	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—GSTM1—kidney cancer	0.000132	0.00339	CbGpPWpGaD
Leucovorin—Decreased appetite—Capecitabine—kidney cancer	0.000131	0.000757	CcSEcCtD
Leucovorin—Nausea—Gemcitabine—kidney cancer	0.00013	0.000753	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00013	0.000752	CcSEcCtD
Leucovorin—Fatigue—Capecitabine—kidney cancer	0.00013	0.000751	CcSEcCtD
Leucovorin—Pruritus—Paclitaxel—kidney cancer	0.00013	0.000751	CcSEcCtD
Leucovorin—Constipation—Capecitabine—kidney cancer	0.000129	0.000745	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.000128	0.00331	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—EGR1—kidney cancer	0.000126	0.00326	CbGpPWpGaD
Leucovorin—Diarrhoea—Paclitaxel—kidney cancer	0.000126	0.000726	CcSEcCtD
Leucovorin—Feeling abnormal—Capecitabine—kidney cancer	0.000124	0.000718	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—GSTM1—kidney cancer	0.000124	0.00319	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000123	0.000712	CcSEcCtD
Leucovorin—Chills—Doxorubicin—kidney cancer	0.000123	0.000709	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.000123	0.00316	CbGpPWpGaD
Leucovorin—Dizziness—Paclitaxel—kidney cancer	0.000122	0.000702	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—kidney cancer	0.000121	0.000698	CcSEcCtD
Leucovorin—Urticaria—Capecitabine—kidney cancer	0.00012	0.000692	CcSEcCtD
Leucovorin—Abdominal pain—Capecitabine—kidney cancer	0.000119	0.000688	CcSEcCtD
Leucovorin—Body temperature increased—Capecitabine—kidney cancer	0.000119	0.000688	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—kidney cancer	0.000119	0.000688	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—ANXA2—kidney cancer	0.000117	0.00302	CbGpPWpGaD
Leucovorin—Vomiting—Paclitaxel—kidney cancer	0.000117	0.000675	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—kidney cancer	0.000117	0.000674	CcSEcCtD
Leucovorin—TYMS—Metabolism—ACY1—kidney cancer	0.000116	0.003	CbGpPWpGaD
Leucovorin—Rash—Paclitaxel—kidney cancer	0.000116	0.000669	CcSEcCtD
Leucovorin—Dermatitis—Paclitaxel—kidney cancer	0.000116	0.000668	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—GSTP1—kidney cancer	0.000114	0.00293	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—MYC—kidney cancer	0.000113	0.00292	CbGpPWpGaD
Leucovorin—Hypersensitivity—Capecitabine—kidney cancer	0.000111	0.000642	CcSEcCtD
Leucovorin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000111	0.000638	CcSEcCtD
Leucovorin—Nausea—Paclitaxel—kidney cancer	0.000109	0.00063	CcSEcCtD
Leucovorin—Asthenia—Capecitabine—kidney cancer	0.000108	0.000625	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000108	0.00278	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000108	0.00278	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000108	0.00278	CbGpPWpGaD
Leucovorin—Malaise—Doxorubicin—kidney cancer	0.000108	0.00062	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—CDKN1B—kidney cancer	0.000107	0.00277	CbGpPWpGaD
Leucovorin—Syncope—Doxorubicin—kidney cancer	0.000107	0.000617	CcSEcCtD
Leucovorin—Pruritus—Capecitabine—kidney cancer	0.000107	0.000616	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—kidney cancer	0.000107	0.000616	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—kidney cancer	0.000105	0.000605	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—GSTM1—kidney cancer	0.000104	0.00269	CbGpPWpGaD
Leucovorin—Convulsion—Doxorubicin—kidney cancer	0.000103	0.000596	CcSEcCtD
Leucovorin—Diarrhoea—Capecitabine—kidney cancer	0.000103	0.000596	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	0.000102	0.00263	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000101	0.00262	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000101	0.00262	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000101	0.00262	CbGpPWpGaD
Leucovorin—Discomfort—Doxorubicin—kidney cancer	0.0001	0.000579	CcSEcCtD
Leucovorin—Dizziness—Capecitabine—kidney cancer	9.98e-05	0.000576	CcSEcCtD
Leucovorin—TYMS—Metabolism—PDHB—kidney cancer	9.89e-05	0.00255	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	9.83e-05	0.00253	CbGpPWpGaD
Leucovorin—Confusional state—Doxorubicin—kidney cancer	9.81e-05	0.000566	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—kidney cancer	9.73e-05	0.000561	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—KCNMA1—kidney cancer	9.71e-05	0.00251	CbGpPWpGaD
Leucovorin—Infection—Doxorubicin—kidney cancer	9.67e-05	0.000558	CcSEcCtD
Leucovorin—ABCC3—Metabolism—ACY1—kidney cancer	9.62e-05	0.00248	CbGpPWpGaD
Leucovorin—Vomiting—Capecitabine—kidney cancer	9.6e-05	0.000554	CcSEcCtD
Leucovorin—Shock—Doxorubicin—kidney cancer	9.57e-05	0.000552	CcSEcCtD
Leucovorin—Thrombocytopenia—Doxorubicin—kidney cancer	9.53e-05	0.00055	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	9.52e-05	0.00246	CbGpPWpGaD
Leucovorin—Rash—Capecitabine—kidney cancer	9.52e-05	0.000549	CcSEcCtD
Leucovorin—Dermatitis—Capecitabine—kidney cancer	9.51e-05	0.000549	CcSEcCtD
Leucovorin—Skin disorder—Doxorubicin—kidney cancer	9.45e-05	0.000545	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IGF2—kidney cancer	9.4e-05	0.00243	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CCBL1—kidney cancer	9.29e-05	0.0024	CbGpPWpGaD
Leucovorin—Anorexia—Doxorubicin—kidney cancer	9.27e-05	0.000535	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	9.04e-05	0.00233	CbGpPWpGaD
Leucovorin—Nausea—Capecitabine—kidney cancer	8.97e-05	0.000517	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—PSMD7—kidney cancer	8.95e-05	0.00231	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—VEGFA—kidney cancer	8.89e-05	0.00229	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—AURKA—kidney cancer	8.71e-05	0.00225	CbGpPWpGaD
Leucovorin—Dyspnoea—Doxorubicin—kidney cancer	8.67e-05	0.0005	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCND1—kidney cancer	8.62e-05	0.00222	CbGpPWpGaD
Leucovorin—Dyspepsia—Doxorubicin—kidney cancer	8.56e-05	0.000494	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.56e-05	0.00221	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.56e-05	0.00221	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.56e-05	0.00221	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—GRB7—kidney cancer	8.47e-05	0.00219	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	8.47e-05	0.00218	CbGpPWpGaD
Leucovorin—Decreased appetite—Doxorubicin—kidney cancer	8.46e-05	0.000488	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.4e-05	0.000485	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—kidney cancer	8.39e-05	0.000484	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—kidney cancer	8.32e-05	0.00048	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.21e-05	0.00212	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—MYC—kidney cancer	8.21e-05	0.00212	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PDHB—kidney cancer	8.18e-05	0.00211	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	8.07e-05	0.00208	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PPAT—kidney cancer	8.06e-05	0.00208	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GLIPR1—kidney cancer	8.06e-05	0.00208	CbGpPWpGaD
Leucovorin—Feeling abnormal—Doxorubicin—kidney cancer	8.02e-05	0.000463	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—PSMD7—kidney cancer	8.01e-05	0.00207	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Doxorubicin—kidney cancer	7.96e-05	0.000459	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—ITPR2—kidney cancer	7.88e-05	0.00203	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—AURKA—kidney cancer	7.79e-05	0.00201	CbGpPWpGaD
Leucovorin—Urticaria—Doxorubicin—kidney cancer	7.73e-05	0.000446	CcSEcCtD
Leucovorin—ABCC3—Metabolism—CCBL1—kidney cancer	7.69e-05	0.00198	CbGpPWpGaD
Leucovorin—Abdominal pain—Doxorubicin—kidney cancer	7.69e-05	0.000444	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—kidney cancer	7.69e-05	0.000444	CcSEcCtD
Leucovorin—TYMS—Metabolism—APRT—kidney cancer	7.49e-05	0.00193	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—FH—kidney cancer	7.49e-05	0.00193	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	7.47e-05	0.00193	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	7.39e-05	0.00191	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	7.23e-05	0.00186	CbGpPWpGaD
Leucovorin—Hypersensitivity—Doxorubicin—kidney cancer	7.17e-05	0.000414	CcSEcCtD
Leucovorin—TYMS—Metabolism—GPC3—kidney cancer	7.04e-05	0.00182	CbGpPWpGaD
Leucovorin—Asthenia—Doxorubicin—kidney cancer	6.98e-05	0.000403	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.96e-05	0.00179	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—kidney cancer	6.91e-05	0.00178	CbGpPWpGaD
Leucovorin—Pruritus—Doxorubicin—kidney cancer	6.88e-05	0.000397	CcSEcCtD
Leucovorin—TYMS—Metabolism—CA2—kidney cancer	6.85e-05	0.00177	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	6.85e-05	0.00177	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ALAD—kidney cancer	6.68e-05	0.00172	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PPAT—kidney cancer	6.67e-05	0.00172	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GLIPR1—kidney cancer	6.67e-05	0.00172	CbGpPWpGaD
Leucovorin—Diarrhoea—Doxorubicin—kidney cancer	6.66e-05	0.000384	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.59e-05	0.0017	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2B—kidney cancer	6.54e-05	0.00169	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	6.53e-05	0.00168	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CTNNB1—kidney cancer	6.53e-05	0.00168	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.52e-05	0.00168	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ST3GAL2—kidney cancer	6.52e-05	0.00168	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	6.52e-05	0.00168	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	6.47e-05	0.00167	CbGpPWpGaD
Leucovorin—Dizziness—Doxorubicin—kidney cancer	6.43e-05	0.000371	CcSEcCtD
Leucovorin—TYMS—Metabolism—ALDH1A1—kidney cancer	6.37e-05	0.00164	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	6.3e-05	0.00163	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—JUN—kidney cancer	6.26e-05	0.00161	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—FH—kidney cancer	6.2e-05	0.0016	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—APRT—kidney cancer	6.2e-05	0.0016	CbGpPWpGaD
Leucovorin—Vomiting—Doxorubicin—kidney cancer	6.19e-05	0.000357	CcSEcCtD
Leucovorin—Rash—Doxorubicin—kidney cancer	6.13e-05	0.000354	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—kidney cancer	6.13e-05	0.000354	CcSEcCtD
Leucovorin—TYMS—Metabolism—PGK1—kidney cancer	6.11e-05	0.00158	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC5A3—kidney cancer	6.11e-05	0.00158	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.06e-05	0.00156	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PTEN—kidney cancer	6.05e-05	0.00156	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—LDHB—kidney cancer	5.99e-05	0.00154	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BRCA2—kidney cancer	5.9e-05	0.00152	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2B—kidney cancer	5.85e-05	0.00151	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GPC3—kidney cancer	5.83e-05	0.0015	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNA1—kidney cancer	5.78e-05	0.00149	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—kidney cancer	5.78e-05	0.000333	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.69e-05	0.00147	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.69e-05	0.00147	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CA2—kidney cancer	5.67e-05	0.00146	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—BIRC5—kidney cancer	5.65e-05	0.00146	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ALAD—kidney cancer	5.53e-05	0.00143	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.5e-05	0.00142	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ST3GAL2—kidney cancer	5.39e-05	0.00139	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.39e-05	0.00139	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNA2—kidney cancer	5.38e-05	0.00139	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.35e-05	0.00138	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—kidney cancer	5.29e-05	0.00136	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ALDH1A1—kidney cancer	5.27e-05	0.00136	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.24e-05	0.00135	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CA9—kidney cancer	5.19e-05	0.00134	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—RAF1—kidney cancer	5.17e-05	0.00133	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.17e-05	0.00133	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.12e-05	0.00132	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC5A3—kidney cancer	5.05e-05	0.0013	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PGK1—kidney cancer	5.05e-05	0.0013	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BIRC5—kidney cancer	5.05e-05	0.0013	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—LDHB—kidney cancer	4.96e-05	0.00128	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IGF2—kidney cancer	4.85e-05	0.00125	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.84e-05	0.00125	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IL2—kidney cancer	4.64e-05	0.0012	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.51e-05	0.00116	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.45e-05	0.00115	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CRABP1—kidney cancer	4.42e-05	0.00114	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.36e-05	0.00112	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.34e-05	0.00112	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.3e-05	0.00111	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CA9—kidney cancer	4.3e-05	0.00111	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.2e-05	0.00108	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—kidney cancer	4.13e-05	0.00107	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ITPR2—kidney cancer	4.1e-05	0.00106	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.08e-05	0.00105	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	3.94e-05	0.00102	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ACHE—kidney cancer	3.74e-05	0.000966	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTT1—kidney cancer	3.74e-05	0.000966	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2A—kidney cancer	3.74e-05	0.000965	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	3.73e-05	0.000962	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CRABP1—kidney cancer	3.65e-05	0.000943	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	3.55e-05	0.000915	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SCARB1—kidney cancer	3.54e-05	0.000914	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS1—kidney cancer	3.51e-05	0.000905	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.44e-05	0.000888	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PSMD7—kidney cancer	3.44e-05	0.000887	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ITPR2—kidney cancer	3.4e-05	0.000876	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2A—kidney cancer	3.35e-05	0.000863	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN1B—kidney cancer	3.31e-05	0.000855	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—BCHE—kidney cancer	3.26e-05	0.000841	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC5A5—kidney cancer	3.22e-05	0.000831	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCND1—kidney cancer	3.16e-05	0.000816	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.13e-05	0.000808	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC2A1—kidney cancer	3.11e-05	0.000802	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTT1—kidney cancer	3.1e-05	0.000799	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ACHE—kidney cancer	3.1e-05	0.000799	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	3.08e-05	0.000794	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN1B—kidney cancer	2.96e-05	0.000764	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SCARB1—kidney cancer	2.93e-05	0.000757	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS1—kidney cancer	2.9e-05	0.000749	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PSMD7—kidney cancer	2.85e-05	0.000734	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND1—kidney cancer	2.83e-05	0.000729	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—BCHE—kidney cancer	2.7e-05	0.000696	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—RAF1—kidney cancer	2.67e-05	0.000688	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC5A5—kidney cancer	2.67e-05	0.000688	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.61e-05	0.000673	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTP1—kidney cancer	2.59e-05	0.000669	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC2A1—kidney cancer	2.57e-05	0.000664	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—kidney cancer	2.54e-05	0.000654	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.5e-05	0.000644	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.48e-05	0.00064	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ABCB1—kidney cancer	2.46e-05	0.000634	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.46e-05	0.000633	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IL2—kidney cancer	2.39e-05	0.000617	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GSTM1—kidney cancer	2.38e-05	0.000615	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MAPK3—kidney cancer	2.33e-05	0.000601	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—RAF1—kidney cancer	2.31e-05	0.000596	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—kidney cancer	2.27e-05	0.000585	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP1A1—kidney cancer	2.26e-05	0.000583	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MAPK1—kidney cancer	2.22e-05	0.000572	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.18e-05	0.000562	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTP1—kidney cancer	2.15e-05	0.000554	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ABCB1—kidney cancer	2.03e-05	0.000524	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—VEGFA—kidney cancer	2.03e-05	0.000524	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GSTM1—kidney cancer	1.97e-05	0.000509	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.95e-05	0.000502	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—MAPK3—kidney cancer	1.92e-05	0.000496	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP1A1—kidney cancer	1.87e-05	0.000483	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—kidney cancer	1.86e-05	0.00048	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—MAPK1—kidney cancer	1.83e-05	0.000472	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—kidney cancer	1.73e-05	0.000446	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—POMC—kidney cancer	1.69e-05	0.000435	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CA—kidney cancer	1.59e-05	0.000409	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.54e-05	0.000396	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—kidney cancer	1.54e-05	0.000396	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—POMC—kidney cancer	1.39e-05	0.00036	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS2—kidney cancer	1.34e-05	0.000347	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTEN—kidney cancer	1.17e-05	0.000302	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS2—kidney cancer	1.11e-05	0.000287	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTEN—kidney cancer	9.7e-06	0.00025	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CA—kidney cancer	8.27e-06	0.000213	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CA—kidney cancer	6.85e-06	0.000177	CbGpPWpGaD
